scPharmaceuticals Inc. Profile Avatar - Palmy Investing

scPharmaceuticals Inc.

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through…

Biotechnology
US, Burlington [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of SCPH's Analysis
CIK: 1604950 CUSIP: 810648105 ISIN: US8106481059 LEI: - UEI: -
Secondary Listings
SCPH has no secondary listings inside our databases.